IND enabling work underway for KEY-Vaxx

I know HER-Vaxx and B-Vaxx are our 2 advanced (potential) wonder drugs but for those of you who may have missed it, today's Half-Yearly Report stated in relation to KEY-Vaxx, that IND enabling work for the vaccine was well underway with preparation for clinical trials continuing.

For those that don't know what "IND enabling work" is:

The U.S Food and Drug Administration's Investigational New Drug (IND) program is the means by which a pharmaceutical company obtains permission to ship an experimental drug across state lines (usually to clinical investigators) before a marketing application for the drug has been approved.

The ASX will soon wake up and realise that IMU is not a 1 trick pony. We have 3, (yes 3!!!!) potential cancer vaccines in the pipeline.

Based on global comparisons, a Market Cap of $300m -$400 million would more accurately reflect the value of all this IP. Therefor, one would assume that a share price of between 8c - 11c will eventually become a reality once the market wakes up???